FDA advises public to be vigilant on fake, unregistered products


SAN FERNANDO CITY, September 24 (PIA) — The Food and Drug Administration (FDA) recently initiated a consumer awareness advocacy among partner government agencies, licensing officers of local government units, and pharmaceutical associations in engaging them in their fight against substandard products.

The FDA is a regulatory enforcement agency under the Department of Health which is mandated to ensure the safety, efficacy, or quality of health products.

Among those being regulated by the FDA are drugs, cosmetics, medical devices, food, urban hazardous, toys, and childcare products.

“We want to put an end to health establishments operating without a license to operate and the spread of unregistered and counterfeit health products not only here in the region but in the country as well,” Jesusa Joyce Cirunay, Director II for the North Luzon cluster.

She added, “The public must be vigilant in buying drug products because counterfeit products pose serious threat to public health and safety and serious adverse health consequences, and drug resistance especially for pharmaceutical products.”

READ:  DSWD supports effort to streamline public access to gov't medical funds

 

Representatives of national government agencies and pharmacuetical associtions, other stakeholders in the region take their pledge of commitment to help advocate licensing and registration of food, medical devices, cosmetics, toys and childcare products. (JDS/PIA-LA Union)

FDA takes pride in its 72- hour turn-around time in providing action to communications; zero backlog on all applications to operate and product registration, and strengthened enforcement of laws and regulations.

Highlight of the Consumer Awareness Forum was the reading and signing of the pledge of commitment among the stakeholders to work with FDA in preventing the proliferation of unregistered, substandard, and hazardous health products.

 

The signing of the pledge of commitment. (JDS/PIA-La Union)

The regulatory enforcement of FDA is in partnership with the Philippine National Police in Task Force Destroy Products Unit for the Consumption of Humans (D-PUNCH).

One of the recent operations of the FDA Regulatory Enforcement Team was against Tarlac-based clinic owned by Dr. Farrah Bunch wherein more than P800,000 worth of unregistered health products being sold at the facility’s pharmacy. 

For more advisories and issuances of the FDA, check their website at www.fda.gov.ph or their facebook account https://www.facebook.com/FDAPhilippines/   (JNPD/JDS/ PIA-1, La Union)

Source: PIA Feed